PATENT CLAIM ANALYSIS

Application Number: 16094243
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["544", "297000"]

Abstract:
The present invention relates to new polymorphic forms of Crystalline Rosuvastatin calcium along with novel processes for crystalline as well as amorphous Rosuvastatin calcium.

Claim (Index 13):
The process of  claim 12  wherein stabilizers used in the preparation of crystalline form M2 or Amorphous Rosuvastatin calcium to increase their stability are selected from butylated hydroxyanisole, butylated hydroxytoluene, propyl gallate etc or a mixture thereof.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 97.0
- Lexical Diversity: 1.13636
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13885509', '12449426', '13574005', '14901721', '13143943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8285069521532162
- 35 USC 102 Novelty (BERT): 0.5441937832713292
- Combined Prediction Score: 0.8000756352650276
- Mean Citation Score: 386.299474
- Max Citation Score: 421.883
- Similarity Product: 293.4251152083873

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test